Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avadel Pharmaceuticals Plc ADR
(NQ:
AVDL
)
16.50
+0.33 (+2.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
464,250
Open
16.28
Bid (Size)
15.42 (2)
Ask (Size)
16.75 (1)
Prev. Close
16.17
Today's Range
16.26 - 16.59
52wk Range
9.500 - 19.09
Shares Outstanding
96,116,323
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AVDL Stock Earnings: Avadel Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
AVDL stock results show that Avadel Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Avadel Pharmaceuticals Stock Sees RS Rating Jump to 82
August 06, 2024
On Tuesday, Avadel Pharmaceuticals stock received a positive adjustment to its Relative Strength (RS) Rating, from 76 to 82.
Via
Investor's Business Daily
Performance
YTD
+15.55%
+15.55%
1 Month
+1.29%
+1.29%
3 Month
+6.52%
+6.52%
6 Month
+27.02%
+27.02%
1 Year
+18.71%
+18.71%
More News
Read More
AVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 08, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
Via
Benzinga
American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
March 05, 2024
Via
Benzinga
A Preview Of Avadel Pharmaceuticals's Earnings
March 01, 2024
Via
Benzinga
Insiders Buying Dorian LPG And 2 Other Stocks
January 17, 2024
Via
Benzinga
Needham Maintains Buy Rating for Avadel Pharmaceuticals: Here's What You Need To Know
December 20, 2023
Via
Benzinga
Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
March 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
Earnings Scheduled For March 4, 2024
March 04, 2024
Via
Benzinga
Avadel Pharmaceuticals Sees Robust Uptake For Its Newly Approved Sleep Disorder Drug
November 08, 2023
Via
Benzinga
Preview: Avadel Pharmaceuticals's Earnings
November 07, 2023
Via
Benzinga
Where Avadel Pharmaceuticals Stands With Analysts
September 25, 2023
Via
Benzinga
Analyst Expectations for Avadel Pharmaceuticals's Future
August 10, 2023
Via
Benzinga
Analyst Expectations for Avadel Pharmaceuticals's Future
June 30, 2023
Via
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
November 08, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What 11 Analyst Ratings Have To Say About Avadel Pharmaceuticals
May 30, 2023
Via
Benzinga
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
August 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
August 07, 2023
Via
Benzinga
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
July 03, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
Via
Benzinga
Canopy Growth, Avadel Pharmaceuticals And Other Big Stocks Moving Lower On Friday
June 23, 2023
Via
Benzinga
Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful'
June 23, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.